Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sosei doses first patient with experimental neurodegenerative drug

pharmatimesDecember 14, 2018

Tag: Sosei , Neurodegeneration , HTL0014242

PharmaSources Customer Service